CD4+CD25+ immunoregulatory T cells may not be involved in controlling autoimmune arthritis

Arthritis Research and Therapy

Volumn 5, Issue 2, 2003, Pages

  Bardos, Tamas ^a   Czipri, Matyas ^a   Vermes, Csaba ^a   Finnegan, Alison ^a,b   Mikecz, Katalin ^a,b,c   Zhang, Jian ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY   (United States)

Author keywords

arthritis; autoimmunity; peripheral tolerance; regulatory T cells

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR; PROTEOGLYCAN;

ANIMAL; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; FEMALE; GENETICS; IMMUNOLOGY; MOUSE; MOUSE MUTANT; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD4; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; FEMALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, SCID; PROTEOGLYCANS; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTE SUBSETS;

EID: 0242273358     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar624     Document Type: Article

References (32)

1. Ozkaynak E, Gao W, Shemmeri N, Wang C, Gutierrez-Ramos JC, Amaral J, Qin S, Rottman JB, Coyle AJ, Hancock WW: Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol. 2001, 2: 591-596. 10.1038/89731. DOI: 10.1038/89731
2. Anderton SM, Wraith DC: Selection and fine-tuning of the autoimmune T-cell repertore. Nat Rev Immunol. 2002, 2: 487-498. 10.1038/nri842. DOI: 10.1038/nri842
3. Ohashi PS: T-cell signaling and autoimmunity: molecular mechanisms of disease. Nat Rev Immunol. 2002, 2: 427-438.
4. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995, 155: 1151-1164.
5. + suppressor T cells. Immunol Rev. 2001, 182: 58-67. 10.1034/j.1600-065X.2001.1820104.x. DOI: 10.1034/j.1600-065X.2001.1820104.x
6. + immunoregulatory T cells that control autoimmune diabetes. Immunity. 2000, 12: 431-440. 10.1016/S1074-7613(00)80195-8. DOI: 10.1016/S1074-7613(00)80195-8
7. + regulatory cells that control intestinal inflammation. J Exp Med. 2000, 192: 295-302. 10.1084/jem.192.2.295. DOI: 10.1084/jem.192.2.295
8. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2000, 192: 303-309. 10.1084/jem.192.2.303. DOI: 10.1084/jem.192.2.303
9. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol. 1998, 10: 1969-1980. 10.1093/intimm/10.12.1969. DOI: 10.1093/intimm/10.12.1969
10. + regulatory T cells is mediated by cell surface-bound transforming growth factorβ. J Exp Med. 2001, 194: 629-644. 10.1084/jem.194.5.629. DOI: 10.1084/jem.194.5.629
11. + regulatory T cells. Curr Opin Immunol. 2001, 13: 644-649. 10.1016/S0952-7915(01)00273-4. DOI: 10.1016/S0952-7915(01)00273-4
12. Ellis JS, Chain BM, Cooke A, Ibrahim MA, Katz DR: Adjuvant composition determines the induction of type II collagen-induced arthritis. Scand J Immunol. 1992, 36: 49-56. DOI: 10.1111/j.1365-3083.1992.tb02939.x
13. Buchmann K, Ostergaard L, Glamann J: Affinity purification of antigen-specific serum immunoglobulin from the European eel (Anguilla anguilla). Scand J Immunol. 1992, 36: 89-97. DOI: 10.1111/j.1365-3083.1992.tb02944.x
14. Buzás E, Mikecz K, Brennan FR, Glant TT: Mediators of autopathogenic effector cells in proteoglycan-induced arthritic and clinically asymptomatic BALB/c mice. Cell Immunol. 1994, 158: 292-304. 10.1006/cimm.1994.1277. DOI: 10.1006/cimm.1994.1277
15. + T cells. Cell Immunol. 1992, 144: 347-357. 10.1016/0008-8749(92)90250-S. DOI: 10.1016/0008-8749(92)90250-S
16. Mikecz K, Glant TT, Buzás E, Poole AR: Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (nonimmunized) BALB/c mice. Arthritis Rheum. 1990, 33: 866-876. DOI: 10.1002/art.1780330614
17. Mikecz K, Glant TT: Migration and homing of lymphocytes to lymphoid and synovial tissues in proteoglycan-induced murine arthritis. Arthritis Rheum. 1994, 37: 1395-1403. DOI: 10.1002/art.1780370919
18. + Th1 cells in a syngeneic system. J Immunol. 2002, 168: 6013-6021. DOI: 10.4049/jimmunol.168.12.6013
19. Buzás EI, Brennan FR, Mikecz K, Garzó M, Negroiu G, Holló K, Cs-Szabo G, Pintye E, Glant TT: A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice. J Immunol. 1995, 155: 2679-2687.
20. Zhang J, Bárdos T, Mikecz K, Finnegan A, Glant TT: Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune arthritis. J Immunol. 2001, 166: 4981-4986. DOI: 10.4049/jimmunol.166.8.4981
21. Glant TT, Cs-Szabó G, Nagase H, Jacobs JJ, Mikecz K: Progressive polyarthritis induced in BALB/c mice by aggrecan from human osteoarthritic cartilage. Arthritis Rheum. 1998, 41: 1007-1018. 10.1002/1529-0131(199806)41:6<1007::AID-ART7>3.0.CO;2-6. DOI: 10.1002/1529-0131(199806)41:6<1007::AID-ART7>3.0.CO;2-6
22. Glant TT, Buzás EI, Finnegan A, Negroiu G, Cs-Szabó G, Mikecz K: Critical role of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation. J Immunol. 1998, 160: 3812-3819.
23. Otto JM, Cs-Szabó G, Gallagher J, Velins S, Mikecz K, Buzás EI, Enders JT, Li Y, Olsen BR, Glant TT: Identification of multiple loci linked to inflammation and autoantibody production by a genome scan of a murine model of rheumatoid arthritis. Arthritis Rheum. 1999, 42: 2524-2531. 10.1002/1529-0131(199912)42:12<2524::AID-ANR4>3.0.CO;2-0. DOI: 10.1002/1529-0131(199912)42:12<2524::AID-ANR4>3.0.CO;2-0
24. Otto JM, Chandrasekaran R, Vermes C, Mikecz K, Finnegan A, Rickert SE, Enders JT, Glant TT: A genome scan using a novel genetic cross identifies new susceptibility loci and traits in a mouse model of rheumatoid arthritis. J Immunol. 2000, 165: 5278-5286. DOI: 10.4049/jimmunol.165.9.5278
25. Glant TT, Bárdos T, Vermes C, Chandrasekaran R, Valdéz JC, Otto JM, Gerard D, Velins S, Lovász G, Zhang J, Mikecz K: Variations in susceptibility to proteoglycan-induced arthritis and spondylitis among C3H substrains of mice. Evidence of genetically acquired resistance to autoimmune disease. Arthritis Rheum. 2001, 44: 682-692. 10.1002/1529-0131(200103)44:3<682::AID-ANR118>3.0.CO;2-E. DOI: 10.1002/1529-0131(200103)44:3<682::AID-ANR118>3.0.CO;2-E
26. Holló K, Glant TT, Garzó M, Finnegan A, Mikecz K, Buzás EI: Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis. Clin Exp Immunol. 2000, 120: 167-173. 10.1046/j.1365-2249.2000.01174.x. DOI: 10.1046/j.1365-2249.2000.01174.x
27. + regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol. 2002, 168: 5979-5983. DOI: 10.4049/jimmunol.168.12.5979
28. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci USA. 2002, 99: 8213-8218. 10.1073/pnas.122224799. DOI: 10.1073/pnas.122224799
29. + T-cell subsets in autoimmunity. Curr Opin Immunol. 1997, 9: 872-883. 10.1016/S0952-7915(97)80192-6. DOI: 10.1016/S0952-7915(97)80192-6
30. Oliveira-dos-Santos AJ, Ho A, Tada Y, Lafaille JJ, Tonegawa S, Mak TW, Penninger JM: CD28 costimulation is crucial for the development of spontaneous autoimmune encephalomyelitis. J Immunol. 1999, 162: 4490-4495.
31. Viola A, Lanzavecchia A: T cell activation determined by T cell receptor number and tunable thresholds. Science. 1996, 273: 104-106. DOI: 10.1126/science.273.5271.104
32. Kane LP, Lin J, Weiss A: It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation. Trends Immunol. 2002, 23: 413-420. 10.1016/S1471-4906(02)02264-0. DOI: 10.1016/S1471-4906(02)02264-0